Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,825Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M--EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)23.4Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book3.710-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.2PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M11,500,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IYH

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

IYH is held by these investors:

IYH: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rapps, MichaelDirector, Director or Senior Officer of 10% Securi 2017-01-16Buy1,200$9.481574.05view
Gridley, Anthony RonaldSenior Officer 2017-01-16Sell1,800$16.94836.84view
Dinwoodie, Tyler Wayne PaulSenior Officer 2017-01-16Buy4,000$0.1793252.94view
Brown, Mark ThomasDirector 2017-01-16Sell29,300$1.3611569.12view
Bebek, IvanDirector 2017-01-16Buy8,990$3.384595.27view
smith, laurie james10% Security Holder, Director, Senior Officer 2017-01-16Buy7,500$0.4138607.32view
MEHR, JEFFREYSenior Officer 2017-01-13Sell50,000$27.91468.61view
Squibb, Geoffrey WayneDirector 2017-01-13Buy267$6.272431.1view
Smith, DavidSenior Officer 2017-01-13Sell15,000$60.38162.84view
Rowlands, William BruceDirector, Senior Officer 2017-01-13Buy20,000$0.15105700view

Quarterly/Annual Reports about IYH:

    News about IYH:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Rising Costs Are a Major Issue in the Healthcare Sector May 25 2017
    Merck & Co.’s Segmental Performance in 1Q17 May 23 2017
    Behind BMY’s Cardiovascular Performance in 1Q17 May 19 2017
    Biotech ETFs Sink After House Passage of Health-Care Bill May 11 2017
    Behind Allergan’s US General Medicines Segment in 1Q17 May 11 2017
    A Prescription for Defense With Healthcare ETFs (IYH) May 05 2017
    Health-care ETFs hold modest gain as House passes Obamacare replacement May 04 2017
    Analysts’ Ratings and Recommendations for Pfizer May 01 2017
    Merck’s 1Q17 Estimates: Revenues Will Likely Decrease May 01 2017
    General Electric’s Healthcare Revenue Rose in 1Q17 Apr 27 2017
    Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1? Apr 24 2017
    Eli Lilly’s Cialis and Other Cardiovascular Products in 1Q17 Apr 24 2017
    Will New Products Help Eli Lilly in 1Q17? Apr 20 2017
    Johnson & Johnson’s 1Q17 Earnings Miss Revenue Estimates Apr 20 2017
    Lackluster J&J Q1 Pushes Healthcare ETFs Down Apr 19 2017
    5 ETFs to Buy If You Love Johnson & Johnson's First-Quarter Earnings Apr 17 2017
    How Bristol-Myers Squibb Stock Performed in 1Q17 Apr 07 2017
    What Wall Street Analysts Recommend for Pfizer Apr 05 2017
    There's Value in Healthcare ETFs Apr 04 2017
    These 2 Charts Show Just How Close We Are to Healthcare Collapse Apr 03 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)